Table I. Patient characteristics
Splenectomy (n = 95)Nonsplenectomy (n = 91)
Age at surgery, y, median (range)58 (25-85)66 (19-88)
Sex, percent female (n)69% (66)47% (43)
BMI, median (range)25.2 (17.4-51.6)25.5 (16.7-38.0)
Follow up, y (range)2.67 (0.088-7.6)4.68 (0.16-7.10)
Deceased, percent (n)26% (25)45% (41)
Cancer, n
 Adenocarcinoma: heada047
 Adenocarcinoma: tail220
 Neuroendocrine tumor: head112
 Neuroendocrine tumor: tail200
 Other tumorsb172
Noncancer, n
 Pancreatic cysts165
 Intraductal papillary mucinous neoplasm1419
 Other pathologiesc56
Node positive, percent (n)34% (32)36% (34)
Tumor, percent (n)
 Locally advancedd19% (18)37% (34)
 Distant metastasise20% (19)10% (9)
  • a Including adenocarcinomas of the extrahepatic bile duct, common bile duct, intrapancreatic bile duct, papilla of Vater, and duodenum.

  • b Including melanoma, ovarian cancer, endometrium cancer, colon cancer, gastrointestinal stromal tumor, and solid pseudopapillary neoplasm.

  • c Including immune thrombocytopenia, pancreatitis, pancreatolithiasis, benign vascular lesions, primary sclerosing cholangitis, and necrosis.

  • d At the time of surgery.

  • e Postsurgery.